warnings
Warnings NOT FOR DIRECT INTRAVENOUS INFUSION
Anticoagulant Citrate Dextrose A
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Anticoagulant Citrate Dextrose A
- Generic name
- ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE
- Manufacturer
- Citra Labs LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 5bcd261e-ebba-4ecb-af22-e5aaeb04499b
- SPL ID
- 9a133b17-0377-431f-b839-3e090fdabd78
- Version
- 5
- Effective date
- 2023-02-14
- Source export date
- 2026-10-12
- Source partition
- 10
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/befa34274042a52f589b22fe2add0b1c6f0a385c96447c28303de164bb144af5/drug-label-0010-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 02:29:15
| Harmonized routes |
|---|
| EXTRACORPOREAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | BN020037 | openfda.application_number | |
| brand name | Anticoagulant Citrate Dextrose A | openfda.brand_name | |
| generic name | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | openfda.generic_name | |
| manufacturer name | Citra Labs LLC | openfda.manufacturer_name | |
| ndc | package | 23731-6051-2 | openfda.package_ndc |
| ndc | package | 23731-6051-1 | openfda.package_ndc |
| ndc | package | 23731-6051-3 | openfda.package_ndc |
| ndc | product | 23731-6051 | openfda.product_ndc |
| ndc11 | package | 23731605102 | derived:openfda.package_ndc |
| ndc11 | package | 23731605101 | derived:openfda.package_ndc |
| ndc11 | package | 23731605103 | derived:openfda.package_ndc |
| spl id | 9a133b17-0377-431f-b839-3e090fdabd78 | id | |
| spl set id | 5bcd261e-ebba-4ecb-af22-e5aaeb04499b | set_id | |
| unii | XF417D3PSL | openfda.unii | |
| unii | B22547B95K | openfda.unii | |
| unii | LX22YL083G | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
Adverse Reactions Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.